RT Journal Article
SR Electronic
T1 Roles of PI3k pan-inhibitors and PI3k-d inhibitors in allergic lung inflammation: systematic review and a meta-analysis
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP 231
DO 10.1183/13993003.congress-2020.231
VO 56
IS suppl 64
A1 Yong Chul Lee
A1 Jong Seung Kim
A1 Jae Seok Jeong
A1 Sam Hyun Kwon
A1 So Ri Kim
YR 2020
UL http://erj.ersjournals.com/content/56/suppl_64/231.abstract
AB Meta-analysis can be applied to study the effectiveness of the summary estimates for experimental papers, producing objective and unbiased results. We investigate the effects of phosphoinositide-3-kinase on the inflammatory profile in allergic mouse models, which are currently under development in signal transduction materials. PubMed, EMBASE and Web of Science databases were searched for relevant literature using the search term "PI3k inhibitor" and "allergy" or "asthma". Cochrane Review Manager and R were used for handling continuous variables. The primary outcomes of the inflammatory profile were divided into cell count and inflammatory cytokines. We used a random effects model to draw a forest plot.Through the database search and subsequent selection, 17 articles were identified. Regarding the cell count, both the PI3k pan-inhibitors and PI3k-δ inhibitors effectively reduced the total cell count, eosinophils, neutrophils and lymphocytes. In contrast to PI3k-δ inhibitors, PI3k pan-inhibitors effectively reduced macrophages. Regarding the inflammatory cytokines, PI3k pan-inhibitors and PI3k-δ inhibitors effectively reduced total IgE, IL-4, IL-5, IL-13, TNF-α, IL-1β, VEGF and have no effect on IL-6.Compared to the PI3k pan-inhibitors, which block all pathways, selective PI3k-δ inhibitors are expected to be relatively less toxic. Regarding the efficacy, PI3k-δ inhibitors have at least the same or better efficacy than PI3k pan-inhibitors in effector cells and inflammatory mediators.FootnotesCite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 231.This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the "pre COVID-19" era”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).